Showing results (31-40 of 221) with videos related to
Sort By:
Pageof 23
Obstetrics and Gynecology|October 1, 1979
Massive exudative ascites produced from a tubal pseudocyst in chronic pelvic inflammatory diseaseJ S Berek, P D DarneyNational Cancer Institute Monograph|October 1, 1975
Surgical resection of tumor bulk in the primary treatment of ovarian carcinomaC T GriffithsAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Surgery during chemotherapy and at relapse of ovarian cancerJ S Berek, C Tropé, I VergoteGynecologic Oncology|March 1, 1993
Solitary recurrent metastasis of epithelial ovarian cancer in the spleenR Farias-Eisner, P Braly, J S BerekGynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B BonavidaObstetrics and Gynecology|February 1, 1988
Controversies in the management of cervical adenocarcinomaE Brand, J S Berek, N F HackerInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancerD N Bryan, R Radbod, J S BerekObstetrics and Gynecology|May 1, 1989
Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patientsP J Boyer, J S Berek, J ZighelboimGynecologic Oncology|March 1, 1993
Primary leiomyosarcoma of the ovary in a perimenarchal femaleB J Monk, R Nieberg, J S BerekAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?T C Hamilton, J S Berek, S B KayePageof 23